Spots Global Cancer Trial Database for Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene Ciloleucel
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene Ciloleucel
Official Title: Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene Ciloleucel
Study ID: NCT05776160
Interventions
Study Description
Brief Summary: The goal of this study is to provide access to axicabtagene ciloleucel for patients diagnosed with a disease approved for treatment with axicabtagene ciloleucel, that is otherwise out of specification for commercial release.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
City of Hope Medical Center, Duarte, California, United States
Colorado Blood Cancer Institute, Denver, Colorado, United States
Winship Cancer Institute, Atlanta, Georgia, United States
Northwestern Memorial Hospital, Chicago, Illinois, United States
The University of Kansas Medical Center, Westwood, Kansas, United States
University of Maryland Cancer Center, Baltimore, Maryland, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Dana Farber Cancer Institute - Chestnut Hill, Boston, Massachusetts, United States
University of Michigan, Ann Arbor, Michigan, United States
Mayo Clinic, Rochester, Minnesota, United States
Washington University School of Medicine- Siteman Cancer Center, Saint Louis, Missouri, United States
University of Nebraska Medical Center, Omaha, Nebraska, United States
UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Cleveland Clinic, Cleveland, Ohio, United States
The Ohio State University Wexner Medical Center- James Cancer Hospital, Columbus, Ohio, United States
Oregon Health & Science University, Portland, Oregon, United States
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Avera Cancer Institute, Sioux Falls, South Dakota, United States
Sarah Cannon Research Institute, Nashville, Tennessee, United States
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Methodist Healthcare System of San Antonio dba Methodist Hospital, San Antonio, Texas, United States
Virginia Commonwealth University, Richmond, Virginia, United States
Fred Hutchinson Cancer Center, Seattle, Washington, United States
Tokyo Medical And Dental University Hospital, Bunkyo-ku, , Japan
Chiba University Hospital, Chiba, , Japan
Hamanomachi Hospital, Fukuokaken, , Japan
Gifu Municipal Hospital, Gifu, , Japan
Kobe City Medical Center General Hospital, Hyogo, , Japan
Hyogo Medical University Hospital, Hyogo, , Japan
University of Tsukuba Hospital, Ibaraki, , Japan
Kanazawa University Hospital, Kanazawa, , Japan
Kumamoto University Hospital, Kumamoto, , Japan
University Hospital Kyoto Prefectural University of Medicine, Kyoto, , Japan
Kyoto University Hospital, Kyoto, , Japan
Tohoku University Hospital, Miyagi, , Japan
Shinshu University Hospital, Nagano, , Japan
Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, , Japan
Nagoya University Hospital, Nagoya, , Japan
Kurashiki Central Hospital, Okayama, , Japan
Osaka University Hospital, Osaka, , Japan
Kansai Medical University Hospital, Osaka, , Japan
Kindai University Hospital, Osaka, , Japan
Hokkaido University Hospital, Sapporo Hokkaido, , Japan
Hamamatsu University Hospital, Shizuoka, , Japan
Jichi Medical University Hospital, Tochigi, , Japan
National Cancer Center Hospital, Tokyo, , Japan
Toranomon Hospital, Tokyo, , Japan
Jikei University Hospital, Tokyo, , Japan
Juntendo University School of Medicine Juntendo Clinic, Tokyo, , Japan
The University of Tokyo Hospital, Tokyo, , Japan
Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, , Japan
Keio University Hospital, Tokyo, , Japan
Yamagata University Hospital, Yamagata, , Japan
Yokohama City University Hospital, Yokohama, , Japan
Contact Details
Name: Kite Study Director
Affiliation: Kite, A Gilead Company
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
